Product Information
FENTANYL 12 MCG/HR PATCH is a generic product labeled by SpecGx LLC, priced at $8.9890 per EA under NDC 00406911276. Its NADAC has been published 266 times since Sep 1, 2021.
FDA first approved this application on Feb 9, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5 ug/h
Manufacturer
SpecGx LLCNDC
00406911276
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
FENTANYLApproval Type
Generic (ANDA)
FDA Application
ANDA077154FDA Approved
2/9/2011
TE Code
AB
On Market Since
5/6/2020
Pharmacological Classes
Price Statistics
The NADAC for FENTANYL 12 MCG/HR PATCH has been published 266 times since Sep 1, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9890 per EA |
|---|---|
| All-time high | $10.9033 (Dec 13, 2023) |
| All-time low | $7.0472 (Dec 22, 2021) |
| 52-week high | $10.1519 |
| 52-week low | $8.9890 |
| Median price | $9.4185 |
| Average price | $9.1288 |
| Largest weekly change | +20.2% (Nov 23, 2022) |
| Weeks tracked | 266 |
| Tracking since | Sep 1, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fentanyl transdermal market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SpecGx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fentanyl transdermal market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENTANYL 12 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for FENTANYL 12 MCG/HR PATCH, manufactured by SpecGx LLC, is $8.9890 per EA (NDC 00406911276), effective Sep 30, 2026.
How has the price of FENTANYL 12 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for FENTANYL 12 MCG/HR PATCH has held within roughly two percent of its current level. It has been tracked across 266 weekly CMS publications since Sep 1, 2021.
What are the highest and lowest recorded NADAC prices for FENTANYL 12 MCG/HR PATCH?
Since Sep 1, 2021, the NADAC for FENTANYL 12 MCG/HR PATCH has ranged from a low of $7.0472 (Dec 22, 2021) to a high of $10.9033 (Dec 13, 2023), with a median of $9.4185 per EA.
Are there cheaper alternatives to FENTANYL 12 MCG/HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of FENTANYL 12 MCG/HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FENTANYL 12 MCG/HR PATCH?
FENTANYL 12 MCG/HR PATCH (NDC 00406911276) is labeled by SpecGx LLC, and CMS classifies it as a generic product.